OSE Immunotherapeutics SA logo

OSE Immunotherapeutics SA


Overview | Financials
Company Name OSE Immunotherapeutics SA
Symbol OSE.PA
Currency EUR
Price 5.94
Market Cap 129,214,626
Dividend Yield 0%
52-week-range 2.705 - 8.63
Industry Biotechnology
Sector Healthcare
CEO Dr. Nicolas Poirier Ph.D.
Website https://www.ose-immuno.com

An error occurred while fetching data.

About OSE Immunotherapeutics SA

OSE Immunotherapeutics SA focuses on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. Its products include Tedopi that is in Phase III clinical stage for the treatment of non-small cell lung cancer, as well as in Phase II clinical trial to

Related Stocks

Novacyt S.A. logo

Novacyt S.A.


0.582 EUR

Amplitude Surgical SA logo

Amplitude Surgical SA


3.22 EUR

MaaT Pharma SA logo

MaaT Pharma SA


6.9 EUR

MDxHealth SA logo

MDxHealth SA


3.02 EUR

Sequana Medical NV logo

Sequana Medical NV


1.485 EUR

Eurofins-Cerep SA logo

Eurofins-Cerep SA


20,000 EUR

UG Healthcare Corporation Limited logo

UG Healthcare Corporation Limited


0.134 SGD


Numbers are in millions USD

Numbers are in millions USD